We are live on
!
Find out more
N
Nuveen Portfolio holdings
AUM
$369B
1-Year Est. Return
31.66%
This Fund
S&P 500
This Quarter
Est. Return
+26.22%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$246B
AUM Growth
+$40.4B
(+20%)
Cap. Flow
-$3.46B
Cap. Flow
% of AUM
-1.41%
Top 10 Holdings %
Top 10 Hldgs %
22.52%
Holding
3,466
New
266
Increased
1,402
Reduced
1,481
Closed
200
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$613M |
| 2 |
Match Group
MTCH
|
+$518M |
| 3 |
Meta Platforms (Facebook)
META
|
+$508M |
| 4 |
RTX Corp
RTX
|
+$456M |
| 5 |
Eli Lilly
LLY
|
+$364M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$828M |
| 2 |
Microsoft
MSFT
|
+$510M |
| 3 |
Gilead Sciences
GILD
|
+$465M |
| 4 |
Merck
MRK
|
+$376M |
| 5 |
Walmart Inc
WMT
|
+$369M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.64% |
| 2 | Healthcare | 14.1% |
| 3 | Financials | 12.4% |
| 4 | Consumer Discretionary | 12.19% |
| 5 | Communication Services | 9.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
476
Alnylam Pharmaceuticals
ALNY
$29.3B
| $67.2M | 0.03% |
453,568
-61,300
| -12% | -$8.26M |
|
477
Northern Trust
NTRS
$33.9B
| $67.2M | 0.03% |
846,541
+71,255
| +9% | +$5.65M |
|
478
Paycom
PAYC
$10B
| $67.1M | 0.03% |
216,746
-890
| -0.4% | -$237K |
|
479
Sarepta Therapeutics
SRPT
$1.77B
| $66.9M | 0.03% |
417,422
+81,180
| +24% | +$11M |
|
480
CubeSmart
CUBE
$9.41B
| $66.9M | 0.03% |
2,477,016
+1,110
| +0% | +$29.3K |
|
481
Palo Alto Networks
PANW
$297B
| $66.2M | 0.03% |
1,730,676
+80,706
| +5% | +$2.84M |
|
482
Cooper Companies
COO
$14.5B
| $66.2M | 0.03% |
933,864
-92,492
| -9% | -$6.86M |
|
483
Oneok
OKE
$54.5B
| $65.8M | 0.03% |
1,981,609
-51,535
| -3% | -$1.68M |
|
484
Carlisle Companies
CSL
$15.4B
| $65.3M | 0.03% |
545,746
-19,036
| -3% | -$2.29M |
|
485
Booz Allen Hamilton
BAH
$9.15B
| $65.1M | 0.03% |
837,288
-150,510
| -15% | -$11.4M |
|
|
CTLT
486
DELISTED
CATALENT, INC.
CTLT
| $64.6M | 0.03% |
881,860
+489,646
| +125% | +$33.2M |
|
487
Insulet
PODD
$9.79B
| $64.2M | 0.03% |
330,659
+8,667
| +3% | +$1.66M |
|
488
American Airlines Group
AAL
$10.6B
| $64.2M | 0.03% |
4,913,179
-1,767,572
| -26% | -$21.4M |
|
489
Nucor
NUE
$62.1B
| $63.8M | 0.03% |
1,539,717
-110,214
| -7% | -$4.45M |
|
490
LPL Financial
LPLA
$28.6B
| $63.5M | 0.03% |
810,318
-109,998
| -12% | -$7.35M |
|
|
HR
491
DELISTED
Healthcare Realty Trust Incorporated
HR
| $63.1M | 0.03% |
2,154,424
-340,374
| -14% | -$10.2M |
|
492
Nasdaq
NDAQ
$52.9B
| $63.1M | 0.03% |
1,583,496
-56,352
| -3% | -$2.1M |
|
493
Corning
GLW
$143B
| $62.9M | 0.03% |
2,427,349
-113,182
| -4% | -$2.57M |
|
494
Lennar Class A
LEN
$21.2B
| $62.8M | 0.03% |
1,053,614
-38,685
| -4% | -$1.98M |
|
495
Enbridge
ENB
$112B
| $61.4M | 0.03% |
2,017,950
-117,950
| -6% | -$3.62M |
|
496
Whirlpool
WHR
$2.82B
| $60.9M | 0.02% |
469,824
-30,542
| -6% | -$3.5M |
|
497
SS&C Technologies
SSNC
$18.6B
| $60.7M | 0.02% |
1,075,437
-796,042
| -43% | -$43.4M |
|
498
Dentsply Sirona
XRAY
$2.43B
| $60.6M | 0.02% |
1,376,215
-178,786
| -11% | -$7.56M |
|
499
Blackstone
BX
$110B
| $60.5M | 0.02% |
1,067,398
+408,372
| +62% | +$21.5M |
|
500
SPS Commerce
SPSC
$2.64B
| $60.4M | 0.02% |
804,462
-70,345
| -8% | -$4.29M |
|
Similar funds
VFT
Nuveen's Q2 2020 Portfolio in Review
As of Q2 2020, Nuveen held 3,466 positions worth $246B, up 20% from $205B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Nuveen's Q2 2020 filing shows 266 new, 1,402 increased, 1,481 reduced and 200 closed positions. Its largest new stake was Zoom: 841,153 shares worth $213M. The largest sale was Amazon, an estimated $828M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.
- Nuveen's largest Q2 2020 buy was Zoom: 841,153 shares worth $213M.
- Nuveen added most to AbbVie in Q2 2020, an estimated $613M increase.
- Nuveen's biggest Q2 2020 reduction was Amazon, cutting an estimated $828M.
- Nuveen fully exited Allergan plc in Q2 2020, selling an estimated $212M.
- Nuveen's ten largest holdings make up 23% of its $246B portfolio in Q2 2020.
- Nuveen opened 266 new positions and closed 200 in Q2 2020.
- Nuveen's portfolio value rose 20% quarter-over-quarter to $246B.
Based on Nuveen's 13F filing for Q2 2020, filed 14 Aug 2020.